 |
|
|
| |
The Pharmacokinetics of Telaprevir and Selected ART Medications in HCV/HIV Coinfected Patients
|
| |
| |
Reported by Jules Levin
IDSA Oct 17-21 2012 San Diego
Joshua Henshaw1, Lisa Mahnke1, Bambang Adiwijaya1, Nathalie Adda1, Raymond Rubin1, Mark S. Sulkowski2, Varun Garg1*
1Vertex Pharmaceuticals Incorporated, Cambridge, MA, USA; 2Johns Hopkins University School of Medicine, Baltimore, MD, USA
|
| |
|
|
|
|
|
